SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Cyclacel Pharmaceutical, Inc. (CYCC)

CYCC RSS Feed
Add CYCC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/13/2017 4:57:57 AM - Followers: 107 - Board type: Free - Posts Today: 0




http://www.cyclacel.com/

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Its orally-available drugs in clinical development include Sapacitabine (CYC682), an oral nucleoside analogue, which is in phase II studies for the treatment of hematological malignancies, such as acute myeloid leukemia in the elderly, myelodysplastic syndromes, cutaneous T-cell lymphoma, and lung cancer; Seliciclib (CYC202), a CDK (cyclin dependent kinase) inhibitor, which is in phase II studies for the treatment of lung cancer and nasopharyngeal cancer; and CYC116, an Aurora kinase and VEGFR2 inhibitor that is in phase I studies for patients with solid tumors. The company, through its subsidiary, ALIGN Pharmaceuticals, LLC, markets directly Xclair Cream for radiation dermatitis, as well as Numoisyn Liquid and Numoisyn Lozenges for xerostomia in the United States. It focuses on building a diversified biopharmaceutical business focused in hematology, oncology, and other therapeutic areas based on a portfolio of commercial products and a development pipeline of novel drug candidates. The company was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.  

Our Pipeline

Applying its core strength in cell cycle biology, Cyclacel is advancing a pipeline of orally available, small molecule, investigational drugs designed to stop uncontrolled cell division. Sapacitabine, our lead drug candidate, is being evaluated in the SEAMLESS pivotal Phase 3 trial in elderly patients with acute myeloid leukemia under a Special Protocol Assessment agreement with the US Food and Drug Administration. For more information on our investigational drug programs and clinical trials, please go to the Research & Development tab above.

Learn more about our clinical trials:

Sapacitabine (CYC682)

An oral nucleoside analogue prodrug that acts through a novel mechanism.

Seliciclib (CYC202)

A novel, first-in-class, orally available, cyclin dependent kinase (CDK) inhibitor.

CYC116

An orally-active inhibitor of Aurora kinases A & B and VEGFR2.

 


SureTrader
Interactive Brokers Advertisement
CYCC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CYCC News: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 12/12/2017 07:00:00 AM
CYCC News: Cyclacel Pharmaceuticals Reports Third Quarter 2017 Financial Results 11/09/2017 04:05:00 PM
CYCC News: Cyclacel Pharmaceuticals to Release Third Quarter 2017 Financial Results 11/02/2017 07:00:00 AM
CYCC News: Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2017 Healthcare Conference 09/21/2017 07:00:00 AM
CYCC News: Cyclacel Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference 09/08/2017 07:00:00 AM
PostSubject
#2314   added 2k to my position today , 1.90 MiguelHammond10 12/13/17 04:57:57 AM
#2313   I'm looking Work Harder 12/10/17 10:54:28 PM
#2312   $CYCC 3 Months Chart http://www.stockscores.c $Pistol Pete$ 12/10/17 08:00:40 PM
#2311   6:45pm Trading4it 12/10/17 05:58:22 PM
#2310   Does anyone know what time the event/presentation is tomorrow? Old_Money 12/10/17 05:23:46 PM
#2309   $CYCC - DJ SEBAS - LONG TERM HOLD https://t.co/lFSMjOV0CX ash111 12/07/17 04:12:58 AM
#2308   Very interesting week ahead. Company is trading about ash111 12/07/17 12:48:30 AM
#2307   Just my take Work Harder 12/06/17 08:00:27 PM
#2306   It could friend Work Harder 12/06/17 07:47:25 PM
#2305   This is additional results, i.e a sub-analysis, see dtdude 12/06/17 07:40:28 PM
#2304   Been presented already Work Harder 12/06/17 07:37:34 PM
#2303   Phase 3 trial data coming on Monday. dtdude 12/06/17 07:31:40 PM
#2302   Yeah that's a good comp. Not sold dtdude 12/06/17 07:30:26 PM
#2301   What data Work Harder 12/06/17 06:59:43 PM
#2300   very interesting arbytrader 12/06/17 06:28:00 PM
#2299   CYCC agree. remained me MRNS ( which i ash111 12/06/17 02:54:53 PM
#2298   This is a total gamble right now, but dtdude 12/06/17 07:09:57 AM
#2297   * * $CYCC Video Chart 12-04-17 * * ClayTrader 12/04/17 05:32:07 PM
#2296   Never mind, I see Work Harder 12/04/17 03:57:25 PM
#2295   Where are you seeing that? Work Harder 12/04/17 03:36:36 PM
#2294   Phase 3 results coming out on dec. 11th. Moto260 12/04/17 03:13:02 PM
#2293   * * $CYCC Video Chart 09-22-17 * * ClayTrader 09/22/17 05:04:26 PM
#2292   low float being manipulated,,shorts succeeding to cover cheap kingsransome 09/22/17 09:55:16 AM
#2291   Short squeeze time? Jess070283 09/22/17 09:03:42 AM
#2290   * * $CYCC Video Chart Analysis 9/21/17 * * ClayTrader 09/21/17 05:06:20 PM
#2289   News leaking,,,,shorts "f"d bigtime myop$$$$ kingsransome 09/21/17 04:02:50 PM
#2288   $CYCC break $2.13 and we go parabolic! aristotelisonassis 09/21/17 03:32:36 PM
#2287   fasten your seatbelts ladies and gents. aristotelisonassis 09/21/17 03:15:52 PM
#2286   bounce Tdash 09/12/17 03:26:32 PM
#2285   I think (correct me if I'm wrong) the Brizdb 07/24/17 10:05:00 PM
#2284   Am in here and coming in for more John Kent 07/22/17 09:29:05 AM
#2283   * * $CYCC Video Chart Analysis 7/21/17 * * ClayTrader 07/21/17 05:47:12 PM
#2282   strong buy and rebound here. Going for a aristotelisonassis 07/21/17 02:02:41 PM
#2281   Big bounce coming! er111a 07/20/17 08:46:14 AM
#2280   What do you see in this company that er111a 07/19/17 03:48:56 PM
#2279   Bad timing is my middle name. Doubled down coupleofsnipes 07/19/17 03:23:25 PM
#2278   I will buy some for bounce play! er111a 07/19/17 02:45:55 PM
#2277   Serious question...if the offering is for $2 and Lone Wolf 07/19/17 10:04:23 AM
#2276   offering is less than the initial offering and kingsransome 07/19/17 08:45:41 AM
#2275   mm took cheap stops out,,wonder why ;) $$$$$ kingsransome 07/19/17 08:11:51 AM
#2274   sorry for your pain, -25% already this morning Northrock 07/19/17 06:05:47 AM
#2273   IN... Let's roll!!! coupleofsnipes 07/13/17 09:26:55 PM
#2272   Got in at Start europtiger 05/12/17 09:34:30 AM
#2271   Good ah europtiger 05/11/17 05:19:23 PM
#2270   Something brewing aaron_03 04/10/17 11:39:13 AM
#2269   Yeah right. steelwundrin 04/06/17 07:58:52 PM
#2268   pending good news !, vispach 04/06/17 03:13:59 PM
#2267   CYCC bullish 6.57 stocktrademan 04/06/17 03:03:18 PM
#2266   Very nice recent move. Artos 04/05/17 10:02:02 AM
#2265   That is certainly what it appears to be. Sage7243 04/04/17 08:01:48 PM
PostSubject